RDHL
Price
$1.43
Change
+$0.20 (+16.26%)
Updated
Sep 5 closing price
Capitalization
3.29M
85 days until earnings call
SNOA
Price
$4.73
Change
+$0.20 (+4.42%)
Updated
Sep 5 closing price
Capitalization
7.77M
Interact to see
Advertisement

RDHL vs SNOA

Header iconRDHL vs SNOA Comparison
Open Charts RDHL vs SNOABanner chart's image
Redhill Biopharma
Price$1.43
Change+$0.20 (+16.26%)
Volume$126.06K
Capitalization3.29M
Sonoma Pharmaceuticals
Price$4.73
Change+$0.20 (+4.42%)
Volume$59.83K
Capitalization7.77M
RDHL vs SNOA Comparison Chart in %
Loading...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RDHL vs. SNOA commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RDHL is a Hold and SNOA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (RDHL: $1.43 vs. SNOA: $4.73)
Brand notoriety: RDHL and SNOA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: RDHL: 19% vs. SNOA: 3%
Market capitalization -- RDHL: $3.29M vs. SNOA: $7.77M
RDHL [@Pharmaceuticals: Generic] is valued at $3.29M. SNOA’s [@Pharmaceuticals: Generic] market capitalization is $7.77M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RDHL’s FA Score shows that 0 FA rating(s) are green whileSNOA’s FA Score has 0 green FA rating(s).

  • RDHL’s FA Score: 0 green, 5 red.
  • SNOA’s FA Score: 0 green, 5 red.
According to our system of comparison, SNOA is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RDHL’s TA Score shows that 5 TA indicator(s) are bullish while SNOA’s TA Score has 4 bullish TA indicator(s).

  • RDHL’s TA Score: 5 bullish, 2 bearish.
  • SNOA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, RDHL is a better buy in the short-term than SNOA.

Price Growth

RDHL (@Pharmaceuticals: Generic) experienced а +6.19% price change this week, while SNOA (@Pharmaceuticals: Generic) price change was +6.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

RDHL is expected to report earnings on Dec 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNOA($7.77M) has a higher market cap than RDHL($3.29M). SNOA YTD gains are higher at: 75.836 vs. RDHL (-76.916). SNOA has higher annual earnings (EBITDA): -3.5M vs. RDHL (-29.5M). RDHL has more cash in the bank: 7.28M vs. SNOA (3.61M). RDHL has less debt than SNOA: RDHL (558K) vs SNOA (675K). SNOA has higher revenues than RDHL: SNOA (14.9M) vs RDHL (3.71M).
RDHLSNOARDHL / SNOA
Capitalization3.29M7.77M42%
EBITDA-29.5M-3.5M844%
Gain YTD-76.91675.836-101%
P/E Ratio0.09N/A-
Revenue3.71M14.9M25%
Total Cash7.28M3.61M202%
Total Debt558K675K83%
FUNDAMENTALS RATINGS
RDHL vs SNOA: Fundamental Ratings
RDHL
SNOA
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
6536
P/E GROWTH RATING
1..100
8058
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SNOA's Valuation (65) in the Pharmaceuticals Other industry is in the same range as RDHL (90) in the Biotechnology industry. This means that SNOA’s stock grew similarly to RDHL’s over the last 12 months.

SNOA's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as RDHL (100) in the Biotechnology industry. This means that SNOA’s stock grew similarly to RDHL’s over the last 12 months.

SNOA's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as RDHL (100) in the Biotechnology industry. This means that SNOA’s stock grew similarly to RDHL’s over the last 12 months.

SNOA's Price Growth Rating (36) in the Pharmaceuticals Other industry is in the same range as RDHL (65) in the Biotechnology industry. This means that SNOA’s stock grew similarly to RDHL’s over the last 12 months.

SNOA's P/E Growth Rating (58) in the Pharmaceuticals Other industry is in the same range as RDHL (80) in the Biotechnology industry. This means that SNOA’s stock grew similarly to RDHL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RDHLSNOA
RSI
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bullish Trend 4 days ago
71%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
76%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 25 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNOA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTHT37.601.21
+3.33%
H World Group Limited
MAGN12.010.07
+0.59%
Magnera Corporation
PSIX86.84-0.08
-0.09%
Power Solutions International Inc
SBLX4.66-0.04
-0.85%
StableX Technologies Inc
PSQH1.61-0.05
-3.01%
PSQ Holdings

SNOA and

Correlation & Price change

A.I.dvisor tells us that SNOA and BNXTF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNOA and BNXTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNOA
1D Price
Change %
SNOA100%
+4.42%
BNXTF - SNOA
29%
Poorly correlated
+2.55%
BGLAF - SNOA
27%
Poorly correlated
N/A
ASRT - SNOA
26%
Poorly correlated
-1.19%
AKAN - SNOA
25%
Poorly correlated
-2.54%
CGC - SNOA
24%
Poorly correlated
+5.80%
More